Cite

HARVARD Citation

    Yoshino, S. et al. (2016). Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701). European journal of cancer. pp. 164-171. [Online]. 
  
Back to record